NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank21
3Y CAGR-22.9%
5Y CAGR-7.5%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-22.9%/yr
vs +3.1%/yr prior
5Y CAGR
-7.5%/yr
Recent deceleration
Acceleration
-25.9pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 3.25 | -25.5% |
| 2024 | 4.37 | +15.0% |
| 2023 | 3.80 | -46.4% |
| 2022 | 7.09 | -3.3% |
| 2021 | 7.33 | +52.1% |
| 2020 | 4.82 | -3.4% |
| 2019 | 4.99 | -20.6% |
| 2018 | 6.28 | -14.3% |
| 2017 | 7.33 | +6.8% |
| 2016 | 6.87 | - |